Unraveling the glomerular RAS: One peptidase at a time

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 3, 2012, Pages

  Harrison Bernard, Lisa M ^a   Chappell, Mark C ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN II [1-8]; ANGIOTENSIN III [2-8]; ANGIOTENSIN IV [3-8]; ANGIOTENSIN[1-7]; CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; PROTEINASE; UNCLASSIFIED DRUG;

ALBUMINURIA; APOPTOSIS; ARTICLE; BIOTRANSFORMATION; BLOOD VESSEL REACTIVITY; CELL COMPARTMENTALIZATION; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; ENDOCYTOSIS; ENDOTHELIUM CELL; GLOMERULUS; GLOMERULUS FILTRATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY INJURY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 84864764015     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00234.2012     Document Type: Article

References (14)

1. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 50: 596-599, 2007.
2. Chappell MC, Gomez MN, Pirro NT, Ferrario CM. Release of angio-tensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension 35: 348-352, 2000.
3. Dhaunsi GS, Yousif MH, Akhtar S, Chappell MC, Diz DI, Benter IF. Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol 638: 108-114, 2010.
4. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 298: F1523-F1532, 2010.
5. Giani JF, Munoz MC, Pons RA, Cao G, Toblli JE, Turyn D, Dominici FP. Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am J Physiol Renal Physiol 300: F272-F282, 2011.
6. Greka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol 74: 299-323, 2012.
7. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R518-R530, 2012.
8. Lorenz JN. Chymase: the other ACE? Am J Physiol Renal Physiol 298: F35-F36, 2010.
9. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 298: F37-F48, 2010.
10. van der Wouden EA, Henning RH, Deelman LE, Roks AJ, Boomsma F, de ZD. Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors. J Renin Angiotensin Aldosterone Syst 6: 96-101, 2005.
11. Velez JC, Bland AM, Arthur JM, Raymond JR, Janech MG. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 293: F398-F407, 2007.
12. Velez JC, Ierardi JL, Bland AM, Morinelli TA, Arthur JM, Raymond JR, Janech MG. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am J Physiol Renal Physiol (March 28, 2012). doi:10.1152/ajprenal.00087.2012.
13. Velez JC, Ryan KJ, Harbeson CE, Bland AM, Budisavljevic MN, Arthur JM, Fitzgibbon WR, Raymond JR, Janech MG. Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli. Hypertension 53: 790-797, 2009.
14. Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 298: F579-F588, 2010.